Centene Corp (NYSE:CNC) reported stronger-than-expected earnings for the fourth quarter of 2024, with an adjusted diluted EPS of $0.80, surpassing the forecast of $0.51. Despite this positive ...

Premier raised its adjusted EPS guidance midpoint by $0.08, reflecting the positive impact of the $200 million share repurchase completed in January. Supply Chain Services revenue guidance midpoint ...

Q2 2025 Earnings Call February 4, 2025 8:00 AM ETCompany ParticipantsBen Krasinski - Senior Director, IRMichael J.

The locus coeruleus is emerging as a major new area of research interest, with many important functions such as regulating ...

Ladies, and gentlemen, thank you for standing by for the Cigna Group fourth-quarter 2024 results review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A ...

Sharps (NASDAQ: STSS) , an innovative medical device and Pharmaceutical packaging company offering patented, best-in-class syringe products, has announced the closing of its firm commitment ...

Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...

Rachel Vatnsdal Olson; Analyst; JPMorgan Chase & Co ...

Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing ...

Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the pricing ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...